Clinical trial
Convalescent Plasma for the Treatment of Coronavirus Disease 2019
NCT04554992 is registered in ClinicalTrials.gov with The Methodist Hospital Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Convalescent Plasma for the Treatment of Coronavirus Disease 2019
- Lead sponsor
- The Methodist Hospital Research Institute
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 20, 2020
- Completion date
- December 20, 2023
- Enrollment
- 350 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19